Medication info
Enpitolyn Tablet 10/10mg

Enpitolyn Tablet 10/10mg

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletSimvastatin›10mg / 1 tablet
Manufacturer / importer
Daehan New Pharm Co., Ltd.
Appearance
A white to light yellow, double-convex, rectangular tablet
Packaging
30 tablets (10 tablets/PTP×3)
Approval status
Active

MFDS item code 201601726 · Approved 2016.03.31 · Insurance code 669906750

Summary

Main use
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
Who takes it
Adults
Adult dose
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less reduction in LDL cholesterol may start with 10/10mg daily. After starting treatment with this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or more. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section on patients with abnormal liver function under 5. General Precautions in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. If higher doses of this medicine are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Ingredients

Manufacturer
Daehan New Pharm Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
  • diabetes
  • hypothyroidism
  • obstructive liver disease
  • chronic renal failure
View approved original text

This medication helps lower elevated total cholesterol and LDL cholesterol levels in patients with primary hypercholesterolemia and mixed hyperlipidemia, reduces ApoB and triglyceride levels, and increases HDL cholesterol. In patients with homozygous familial hypercholesterolemia, it is used in combination with or as an alternative to other lipid-lowering treatments. This medication must be administered alongside appropriate dietary measures and is used as an adjunct when diet alone proves insufficient. It is important to identify and address secondary causes such as diabetes or hypothyroidism before commencing treatment. The efficacy of treatment is monitored through regular tests of total cholesterol, LDL, HDL, and triglycerides. Through this process, the medication effectively improves hypercholesterolemia.

How to take

Adult dose

Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. This medicine is administered once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dose range for this medicine is 10/10mg~10/40mg daily. The generally recommended initial dose is 10/20mg daily. Patients who require less reduction in LDL cholesterol may start with 10/10mg daily. After starting treatment with this medicine or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of 4 weeks or more. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken this medicine at 10/80 mg for 12 months or more without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg daily, administered once daily in the evening. This medicine is administered as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see section on patients with abnormal liver function under 5. General Precautions in Precautions for Use). Administration to patients with renal impairment and chronic kidney disease No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer this medicine at 10/20mg once daily in the evening. If higher doses of this medicine are administered to these patients, use caution and monitor them closely (see 5. General Precautions under Precautions for Use). Administration to elderly patients No dose adjustment is necessary in elderly patients. Concomitant administration with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients receiving this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed a dose of 10/10mg/day of this medicine. Patients receiving this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed a dose of 10/20mg/day of this medicine.

Precautions

This medication is primarily used to lower cholesterol. Serious muscle-related side effects, such as myopathy and rhabdomyolysis, may occur, so if muscle pain or weakness appears, you should immediately inform your physician. The risk of these side effects increases especially with high doses; therefore, dosage adjustment is crucial. Patients with hypersensitivity to this medication, active liver disease, and pregnant or breastfeeding women should not take it. Additionally, the risk of muscle damage increases when used in combination with certain potent drugs, so you must inform your doctor or pharmacist of any other medications you are taking. Patients with muscle weakness or ocular muscle weakness must use the medication cautiously and discontinue use if these symptoms worsen. Patients with liver dysfunction should undergo regular liver function tests, and should discontinue use immediately if signs of liver damage occur. Some patients may experience side effects such as headaches, diarrhea, cold symptoms, muscle pain, limb pain, fatigue, nausea, abdominal pain, constipation, upper abdominal pain, vomiting, chest pain, chest discomfort, weakness, sensory loss, cough, edema, thirst, facial swelling, fainting, insomnia, gastritis, atrophic gastritis, dyspepsia, mucus in stool, irritable bowel syndrome, sore throat, nocturia, hematuria, itching, weight loss, dizziness, sensory abnormalities, depression, cholelithiasis, cholecystitis, alopecia.

Side effects

  • Myopathy
  • rhabdomyolysis
  • elevated creatine kinase
  • headache
  • diarrhea
  • influenza
  • upper respiratory infection
  • myalgia
  • limb pain
  • fatigue
Show 104 more
  • abdominal pain
  • viral infection
  • pharyngitis
  • sinusitis
  • arthralgia
  • lumbago
  • cough
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • elevated liver amino transferase levels
  • hepatitis
  • thrombocytopenia
  • nausea
  • pancreatitis
  • dizziness
  • paresthesia
  • depression
  • cholelithiasis
  • cholecystitis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • eosinophilia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • liver damage
  • myasthenia
  • cataract
  • constipation
  • dyspepsia
  • flatulence
  • nausea
  • eczema
  • pruritus
  • rash
  • muscle cramps
  • specific cranial nerve dysfunction
  • oculomotor dysfunction
  • facial incomplete paralysis
  • tremor
  • peripheral neuropathy
  • peripheral nerve paralysis
  • mental disorders
  • anxiety
  • sleep disorders
  • memory impairment
  • forgetfulness
  • amnesia
  • cognitive impairment
  • confusion
  • interstitial lung disease
  • angioedema
  • lupus-like erythematosus syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibody
  • increased erythrocyte sedimentation rate
  • arthritis
  • fever
  • chills
  • flushing
  • malaise
  • dyspnea
  • cholestatic jaundice
  • liver fat changes
  • cirrhosis
  • fulminant hepatic necrosis
  • liver cancer
  • liver failure
  • loss of appetite
  • vomiting
  • alopecia
  • various skin changes
  • lichenoid drug eruption
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • ophthalmoplegia
  • anemia
  • elevated amino transferases
  • increased ALP
  • elevated γ-GT
  • increased bilirubin levels
  • thyroid dysfunction
  • elevated serum creatine kinase
  • weight loss
  • edema
  • thirst
  • facial edema
  • syncope
  • insomnia
  • gastritis
  • atrophic gastritis
  • mucous stool
  • irritable bowel syndrome
  • sore throat
  • nocturia
  • hematuria
  • increased serum creatine phosphokinase

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture; therefore, it must be stored in a tightly sealed container. The storage temperature should be maintained at room temperature between 1 degree and 30 degrees. This will help keep the medication effective for a longer period.

Appearance and packaging

Appearance

A white to light yellow, double-convex, rectangular tablet

Package unit

30 tablets (10 tablets/PTP×3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.